author_facet Holdcraft, Robert W.
Gazda, Lawrence S.
Circle, Lisa
Adkins, Hollie
Harbeck, Steven G.
Meyer, Eric D.
Bautista, Melissa A.
Martis, Prithy C.
Laramore, Melissa A.
Vinerean, Horatiu V.
Hall, Richard D.
Smith, Barry H.
Holdcraft, Robert W.
Gazda, Lawrence S.
Circle, Lisa
Adkins, Hollie
Harbeck, Steven G.
Meyer, Eric D.
Bautista, Melissa A.
Martis, Prithy C.
Laramore, Melissa A.
Vinerean, Horatiu V.
Hall, Richard D.
Smith, Barry H.
author Holdcraft, Robert W.
Gazda, Lawrence S.
Circle, Lisa
Adkins, Hollie
Harbeck, Steven G.
Meyer, Eric D.
Bautista, Melissa A.
Martis, Prithy C.
Laramore, Melissa A.
Vinerean, Horatiu V.
Hall, Richard D.
Smith, Barry H.
spellingShingle Holdcraft, Robert W.
Gazda, Lawrence S.
Circle, Lisa
Adkins, Hollie
Harbeck, Steven G.
Meyer, Eric D.
Bautista, Melissa A.
Martis, Prithy C.
Laramore, Melissa A.
Vinerean, Horatiu V.
Hall, Richard D.
Smith, Barry H.
Cell Transplantation
Enhancement of in Vitro and in Vivo Function of Agarose-Encapsulated Porcine Islets by Changes in the Islet Microenvironment
Transplantation
Cell Biology
Biomedical Engineering
author_sort holdcraft, robert w.
spelling Holdcraft, Robert W. Gazda, Lawrence S. Circle, Lisa Adkins, Hollie Harbeck, Steven G. Meyer, Eric D. Bautista, Melissa A. Martis, Prithy C. Laramore, Melissa A. Vinerean, Horatiu V. Hall, Richard D. Smith, Barry H. 0963-6897 1555-3892 SAGE Publications Transplantation Cell Biology Biomedical Engineering http://dx.doi.org/10.3727/096368913x667033 <jats:p> The transplantation of porcine islets of Langerhans to treat type 1 diabetes may provide a solution to the demand for insulin-producing cells. Porcine islets encapsulated in agarose–agarose macrobeads have been shown to function in nonimmunosuppressed xenogeneic models of both streptozotocin-induced and autoimmune type 1 diabetes. One advantage of agarose encapsulation is the ability to culture macrobeads for extended periods, permitting microbiological and functional assessment. Herein we describe optimization of the agarose matrix that results in improved islet function. Porcine islets (500 IEQs) from retired breeding sows were encapsulated in 1.5% SeaKem Gold (SG), 0.8% SG, or 0.8% Litex (Li) agarose, followed by an outer capsule of 5% SG agarose. Insulin production by the encapsulated islets exhibited an agarose-specific effect with 20% (0.8% SG) to 50% (0.8% Li) higher initial insulin production relative to 1.5% SG macrobeads. Insulin production was further increased by 40–50% from week 2 to week 12 in both agarose types at the 0.8% concentration, whereas islets encapsulated in 1.5% SG agarose increased insulin production by approximately 20%. Correspondingly, fewer macrobeads were required to restore normoglycemia in streptozotocin-induced diabetic female CD(SD) rats that received 0.8% Li (15 macrobeads) or 0.8% SG (17 macrobeads) as compared to 1.5% SG (19 macrobeads). Islet cell proliferation was also observed during the first 2 months postencapsulation, peaking at 4 weeks, where approximately 50% of islets contained proliferative cells, including β-cells, regardless of agarose type. These results illustrate the importance of optimizing the microenvironment of encapsulated islets to improve islet performance and advance the potential of islet xenotransplantation for the treatment of type 1 diabetes. </jats:p> Enhancement of in Vitro and in Vivo Function of Agarose-Encapsulated Porcine Islets by Changes in the Islet Microenvironment Cell Transplantation
doi_str_mv 10.3727/096368913x667033
facet_avail Online
Free
finc_class_facet Medizin
Biologie
Technik
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMzcyNy8wOTYzNjg5MTN4NjY3MDMz
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMzcyNy8wOTYzNjg5MTN4NjY3MDMz
institution DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
imprint SAGE Publications, 2014
imprint_str_mv SAGE Publications, 2014
issn 0963-6897
1555-3892
issn_str_mv 0963-6897
1555-3892
language English
mega_collection SAGE Publications (CrossRef)
match_str holdcraft2014enhancementofinvitroandinvivofunctionofagaroseencapsulatedporcineisletsbychangesintheisletmicroenvironment
publishDateSort 2014
publisher SAGE Publications
recordtype ai
record_format ai
series Cell Transplantation
source_id 49
title Enhancement of in Vitro and in Vivo Function of Agarose-Encapsulated Porcine Islets by Changes in the Islet Microenvironment
title_unstemmed Enhancement of in Vitro and in Vivo Function of Agarose-Encapsulated Porcine Islets by Changes in the Islet Microenvironment
title_full Enhancement of in Vitro and in Vivo Function of Agarose-Encapsulated Porcine Islets by Changes in the Islet Microenvironment
title_fullStr Enhancement of in Vitro and in Vivo Function of Agarose-Encapsulated Porcine Islets by Changes in the Islet Microenvironment
title_full_unstemmed Enhancement of in Vitro and in Vivo Function of Agarose-Encapsulated Porcine Islets by Changes in the Islet Microenvironment
title_short Enhancement of in Vitro and in Vivo Function of Agarose-Encapsulated Porcine Islets by Changes in the Islet Microenvironment
title_sort enhancement of in vitro and in vivo function of agarose-encapsulated porcine islets by changes in the islet microenvironment
topic Transplantation
Cell Biology
Biomedical Engineering
url http://dx.doi.org/10.3727/096368913x667033
publishDate 2014
physical 929-944
description <jats:p> The transplantation of porcine islets of Langerhans to treat type 1 diabetes may provide a solution to the demand for insulin-producing cells. Porcine islets encapsulated in agarose–agarose macrobeads have been shown to function in nonimmunosuppressed xenogeneic models of both streptozotocin-induced and autoimmune type 1 diabetes. One advantage of agarose encapsulation is the ability to culture macrobeads for extended periods, permitting microbiological and functional assessment. Herein we describe optimization of the agarose matrix that results in improved islet function. Porcine islets (500 IEQs) from retired breeding sows were encapsulated in 1.5% SeaKem Gold (SG), 0.8% SG, or 0.8% Litex (Li) agarose, followed by an outer capsule of 5% SG agarose. Insulin production by the encapsulated islets exhibited an agarose-specific effect with 20% (0.8% SG) to 50% (0.8% Li) higher initial insulin production relative to 1.5% SG macrobeads. Insulin production was further increased by 40–50% from week 2 to week 12 in both agarose types at the 0.8% concentration, whereas islets encapsulated in 1.5% SG agarose increased insulin production by approximately 20%. Correspondingly, fewer macrobeads were required to restore normoglycemia in streptozotocin-induced diabetic female CD(SD) rats that received 0.8% Li (15 macrobeads) or 0.8% SG (17 macrobeads) as compared to 1.5% SG (19 macrobeads). Islet cell proliferation was also observed during the first 2 months postencapsulation, peaking at 4 weeks, where approximately 50% of islets contained proliferative cells, including β-cells, regardless of agarose type. These results illustrate the importance of optimizing the microenvironment of encapsulated islets to improve islet performance and advance the potential of islet xenotransplantation for the treatment of type 1 diabetes. </jats:p>
container_issue 8
container_start_page 929
container_title Cell Transplantation
container_volume 23
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792335069487038468
geogr_code not assigned
last_indexed 2024-03-01T14:38:42.046Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Enhancement+of+in+Vitro+and+in+Vivo+Function+of+Agarose-Encapsulated+Porcine+Islets+by+Changes+in+the+Islet+Microenvironment&rft.date=2014-08-01&genre=article&issn=1555-3892&volume=23&issue=8&spage=929&epage=944&pages=929-944&jtitle=Cell+Transplantation&atitle=Enhancement+of+in+Vitro+and+in+Vivo+Function+of+Agarose-Encapsulated+Porcine+Islets+by+Changes+in+the+Islet+Microenvironment&aulast=Smith&aufirst=Barry+H.&rft_id=info%3Adoi%2F10.3727%2F096368913x667033&rft.language%5B0%5D=eng
SOLR
_version_ 1792335069487038468
author Holdcraft, Robert W., Gazda, Lawrence S., Circle, Lisa, Adkins, Hollie, Harbeck, Steven G., Meyer, Eric D., Bautista, Melissa A., Martis, Prithy C., Laramore, Melissa A., Vinerean, Horatiu V., Hall, Richard D., Smith, Barry H.
author_facet Holdcraft, Robert W., Gazda, Lawrence S., Circle, Lisa, Adkins, Hollie, Harbeck, Steven G., Meyer, Eric D., Bautista, Melissa A., Martis, Prithy C., Laramore, Melissa A., Vinerean, Horatiu V., Hall, Richard D., Smith, Barry H., Holdcraft, Robert W., Gazda, Lawrence S., Circle, Lisa, Adkins, Hollie, Harbeck, Steven G., Meyer, Eric D., Bautista, Melissa A., Martis, Prithy C., Laramore, Melissa A., Vinerean, Horatiu V., Hall, Richard D., Smith, Barry H.
author_sort holdcraft, robert w.
container_issue 8
container_start_page 929
container_title Cell Transplantation
container_volume 23
description <jats:p> The transplantation of porcine islets of Langerhans to treat type 1 diabetes may provide a solution to the demand for insulin-producing cells. Porcine islets encapsulated in agarose–agarose macrobeads have been shown to function in nonimmunosuppressed xenogeneic models of both streptozotocin-induced and autoimmune type 1 diabetes. One advantage of agarose encapsulation is the ability to culture macrobeads for extended periods, permitting microbiological and functional assessment. Herein we describe optimization of the agarose matrix that results in improved islet function. Porcine islets (500 IEQs) from retired breeding sows were encapsulated in 1.5% SeaKem Gold (SG), 0.8% SG, or 0.8% Litex (Li) agarose, followed by an outer capsule of 5% SG agarose. Insulin production by the encapsulated islets exhibited an agarose-specific effect with 20% (0.8% SG) to 50% (0.8% Li) higher initial insulin production relative to 1.5% SG macrobeads. Insulin production was further increased by 40–50% from week 2 to week 12 in both agarose types at the 0.8% concentration, whereas islets encapsulated in 1.5% SG agarose increased insulin production by approximately 20%. Correspondingly, fewer macrobeads were required to restore normoglycemia in streptozotocin-induced diabetic female CD(SD) rats that received 0.8% Li (15 macrobeads) or 0.8% SG (17 macrobeads) as compared to 1.5% SG (19 macrobeads). Islet cell proliferation was also observed during the first 2 months postencapsulation, peaking at 4 weeks, where approximately 50% of islets contained proliferative cells, including β-cells, regardless of agarose type. These results illustrate the importance of optimizing the microenvironment of encapsulated islets to improve islet performance and advance the potential of islet xenotransplantation for the treatment of type 1 diabetes. </jats:p>
doi_str_mv 10.3727/096368913x667033
facet_avail Online, Free
finc_class_facet Medizin, Biologie, Technik
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMzcyNy8wOTYzNjg5MTN4NjY3MDMz
imprint SAGE Publications, 2014
imprint_str_mv SAGE Publications, 2014
institution DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1
issn 0963-6897, 1555-3892
issn_str_mv 0963-6897, 1555-3892
language English
last_indexed 2024-03-01T14:38:42.046Z
match_str holdcraft2014enhancementofinvitroandinvivofunctionofagaroseencapsulatedporcineisletsbychangesintheisletmicroenvironment
mega_collection SAGE Publications (CrossRef)
physical 929-944
publishDate 2014
publishDateSort 2014
publisher SAGE Publications
record_format ai
recordtype ai
series Cell Transplantation
source_id 49
spelling Holdcraft, Robert W. Gazda, Lawrence S. Circle, Lisa Adkins, Hollie Harbeck, Steven G. Meyer, Eric D. Bautista, Melissa A. Martis, Prithy C. Laramore, Melissa A. Vinerean, Horatiu V. Hall, Richard D. Smith, Barry H. 0963-6897 1555-3892 SAGE Publications Transplantation Cell Biology Biomedical Engineering http://dx.doi.org/10.3727/096368913x667033 <jats:p> The transplantation of porcine islets of Langerhans to treat type 1 diabetes may provide a solution to the demand for insulin-producing cells. Porcine islets encapsulated in agarose–agarose macrobeads have been shown to function in nonimmunosuppressed xenogeneic models of both streptozotocin-induced and autoimmune type 1 diabetes. One advantage of agarose encapsulation is the ability to culture macrobeads for extended periods, permitting microbiological and functional assessment. Herein we describe optimization of the agarose matrix that results in improved islet function. Porcine islets (500 IEQs) from retired breeding sows were encapsulated in 1.5% SeaKem Gold (SG), 0.8% SG, or 0.8% Litex (Li) agarose, followed by an outer capsule of 5% SG agarose. Insulin production by the encapsulated islets exhibited an agarose-specific effect with 20% (0.8% SG) to 50% (0.8% Li) higher initial insulin production relative to 1.5% SG macrobeads. Insulin production was further increased by 40–50% from week 2 to week 12 in both agarose types at the 0.8% concentration, whereas islets encapsulated in 1.5% SG agarose increased insulin production by approximately 20%. Correspondingly, fewer macrobeads were required to restore normoglycemia in streptozotocin-induced diabetic female CD(SD) rats that received 0.8% Li (15 macrobeads) or 0.8% SG (17 macrobeads) as compared to 1.5% SG (19 macrobeads). Islet cell proliferation was also observed during the first 2 months postencapsulation, peaking at 4 weeks, where approximately 50% of islets contained proliferative cells, including β-cells, regardless of agarose type. These results illustrate the importance of optimizing the microenvironment of encapsulated islets to improve islet performance and advance the potential of islet xenotransplantation for the treatment of type 1 diabetes. </jats:p> Enhancement of in Vitro and in Vivo Function of Agarose-Encapsulated Porcine Islets by Changes in the Islet Microenvironment Cell Transplantation
spellingShingle Holdcraft, Robert W., Gazda, Lawrence S., Circle, Lisa, Adkins, Hollie, Harbeck, Steven G., Meyer, Eric D., Bautista, Melissa A., Martis, Prithy C., Laramore, Melissa A., Vinerean, Horatiu V., Hall, Richard D., Smith, Barry H., Cell Transplantation, Enhancement of in Vitro and in Vivo Function of Agarose-Encapsulated Porcine Islets by Changes in the Islet Microenvironment, Transplantation, Cell Biology, Biomedical Engineering
title Enhancement of in Vitro and in Vivo Function of Agarose-Encapsulated Porcine Islets by Changes in the Islet Microenvironment
title_full Enhancement of in Vitro and in Vivo Function of Agarose-Encapsulated Porcine Islets by Changes in the Islet Microenvironment
title_fullStr Enhancement of in Vitro and in Vivo Function of Agarose-Encapsulated Porcine Islets by Changes in the Islet Microenvironment
title_full_unstemmed Enhancement of in Vitro and in Vivo Function of Agarose-Encapsulated Porcine Islets by Changes in the Islet Microenvironment
title_short Enhancement of in Vitro and in Vivo Function of Agarose-Encapsulated Porcine Islets by Changes in the Islet Microenvironment
title_sort enhancement of in vitro and in vivo function of agarose-encapsulated porcine islets by changes in the islet microenvironment
title_unstemmed Enhancement of in Vitro and in Vivo Function of Agarose-Encapsulated Porcine Islets by Changes in the Islet Microenvironment
topic Transplantation, Cell Biology, Biomedical Engineering
url http://dx.doi.org/10.3727/096368913x667033